Association between gene-level methylation scores (AHRR*, MYO1G, CYP1A1, FRMD4A, and GFI1*) and lung cancer risk, among ever smokers (186 matched pairs) nested in the CLUE II cohort (1989–2018). This evidence concerns the gene FRMD4A and lung carcinoma.